In Silico Evaluation of the Anti-inflammatory Potential of Rubiacordifolia (Manjistha) Phytoconstituents: Molecular Docking and ADMET Profiling
TMP Universal Journal of Advances in Pharmaceutical Sciences · 19.11.2026 · 2 (4)
DOI: 10.69557/823e7r73 ↗Kurz gefasst
Fachartikel in der Zeitschrift TMP Universal Journal of Advances in Pharmaceutical Sciences, online erschienen am 19.11.2026. Verfasst von Sachin Jain.
Abstract (Originalsprache)
Objective
To investigate the anti-inflammatory potential of selected phytoconstituents of Rubiacordifolia (Manjistha) using molecular docking and computational pharmacokinetic profiling.
Methods
A hydroalcoholic extract of R. cordifolia roots was prepared by Soxhlet extraction and the percentage yield was determined. Four major phytoconstituents, namely purpurin, rubiadin, alizarin and mollugin, were selected through literature survey and database screening, and their structures were retrieved from PubChem. Molecular docking was performed with AutoDock Vina against inflammatory target proteins (cyclooxygenase-2, COX-2; tumor necrosis factor-alpha, TNF-α; and nuclear factor-kappa B, NF-κB). Ligand–protein interactions were visualised in PyMOL. Drug-likeness and pharmacokinetic properties were predicted with SwissADME and assessed against Lipinski's Rule of Five.
Results
The hydroalcoholic extract gave a yield of 13.7 ± 0.3% w/w. Purpurin showed the highest binding affinity towards COX-2 (−8.6 ± 0.3 kcal/mol) and formed four hydrogen bonds with ARG120, TYR355 and SER530. Mollugin (−8.1 ± 0.5 kcal/mol), rubiadin (−7.9 ± 0.4 kcal/mol) and alizarin (−7.4 ± 0.2 kcal/mol) also bound within the active site. All four compounds satisfied Lipinski's Rule of Five with no violations, and purpurin, rubiadin and mollugin were predicted to have high gastrointestinal absorption.
Conclusion
Purpurin and mollugin emerged as the most promising COX-2-interacting constituents of R. cordifolia, with favourable drug-like properties. These findings provide computational support for the traditional use of Manjistha in inflammatory conditions and justify in vitro and in vivo validation.
Zitieren
APA
Jain, S. (2026). In Silico Evaluation of the Anti-inflammatory Potential of Rubiacordifolia (Manjistha) Phytoconstituents: Molecular Docking and ADMET Profiling. TMP Universal Journal of Advances in Pharmaceutical Sciences, 2(4). https://doi.org/10.69557/823e7r73
Vancouver
Jain S. In Silico Evaluation of the Anti-inflammatory Potential of Rubiacordifolia (Manjistha) Phytoconstituents: Molecular Docking and ADMET Profiling. TMP Universal Journal of Advances in Pharmaceutical Sciences. 2026;2(4). doi:10.69557/823e7r73
BibTeX
@article{Jain2026,
author = {Jain, Sachin},
title = {In Silico Evaluation of the Anti-inflammatory Potential of Rubiacordifolia (Manjistha) Phytoconstituents: Molecular Docking and ADMET Profiling},
journal = {TMP Universal Journal of Advances in Pharmaceutical Sciences},
year = {2026},
volume = {2},
number = {4},
doi = {10.69557/823e7r73}
}
EUVIMED